Table 1.
Application | Antifungal agent | Concentration (mM) | Lesion length (mm)a | Significanceb |
---|---|---|---|---|
Preventive | KA | 10 | 4.38 ± 0.58 | ns |
20 | 2.13 ± 0.22 | * | ||
50 | 0 | - | ||
Carbendazim | 20 | 2.07 ± 0.70 | * | |
50 | 0 | - | ||
Prochloraz | 20 | 2.75 ± 0.67 | * | |
50 | 0 | - | ||
Control (water) | - | 5.88 ± 0.95 | - | |
Curative | KA | 20 | 3.78 ± 0.42 | * |
50 | 1.63 ± 0.27 | *** | ||
Carbendazim | 20 | 3.85 ± 0.41 | * | |
50 | 1.88 ± 0.16 | **** | ||
Prochloraz | 20 | 4.00 ± 0.39 | * | |
50 | 1.75 ± 0.17 | **** | ||
KA + Carbendazim | 10 (KA), 10 (Carbendazim) | 1.84 ± 0.28 | *** | |
KA + Prochloraz | 10 (KA), 10 (Prochloraz) | 2.23 ± 0.82 | * | |
Carbendazim + Prochloraz | 10 (Carbendazim), 10 (Prochloraz) | 2.43 ± 0.50 | ** | |
KA + Carbendazim + Prochloraz | 10 (KA), 10 (Carbendazim), 10 (Prochloraz) | 0.96 ± 0.35 | **** | |
Control (water) | - | 4.83 ± 0.14 | - |
Lesion length (n = 60) ± SD.
Significance levels: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; and no significance (ns).